Approval · Notice of Compliance 18359 · 2016
ZEVALIN: Notice of Compliance 18359
Issued August 11, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18359
- Date
- August 11, 2016
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEVALIN | Not yet assigned | — |
Medicinal ingredients
- IBRITUMOMAB TIUXETAN 1.6 MG per ML